Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Patients with severe NPDR had a significantly higher ApoB/ApoA-I ratio (0.70 (0.57 to 0.87) vs. 0.61 (0.49 to 0.72), p = 0.049) and lower vitamin D (52.45 (43.10 to 70.60) ng/mL vs. 40.05 (25.95 to 55.30) ng/mL, p = 0.025).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Observational study.

Observational study

Observes exposures and outcomes without assigning the exposure; the subtype is not established here.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This prospective observational study was conducted at the Department of Ophthalmology, University Hospital Centre Split in Croatia from March 2022 to March 2023.

Source: Methods.

Patients aged 18 years and older suffering from T2DM, NPDR, and DME were included in this research.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The Predictors of Early Treatment Effectiveness of Intravitreal Bevacizumab Application in Patients with Diabetic Macular Edema

Observational study · Diagnostics · 2024

Original publication title

The Predictors of Early Treatment Effectiveness of Intravitreal Bevacizumab Application in Patients with Diabetic Macular Edema

Karla Katić; Josip Katić; Marko Kumrić; Joško Božić; Leida Tandara; Daniela Šupe Domić; Kajo Bućan

© 2024 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The aim of this study was to establish whether multiple blood parameters might predict an early treatment response to intravitreal bevacizumab injections in patients with diabetic macular edema (DME). Seventy-eight patients with non-proliferative diabetic retinopathy (NPDR) and DME were included. The treatment response was evaluated with central macular thickness decrease and best corrected visual acuity increase one month after the last bevacizumab injection. Parameters of interest were the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), vitamin D, and apolipoprotein B to A-I ratio (ApoB/ApoA-I).

The NLR (2.03 ± 0.70 vs. 2.80 ± 1.08; p < 0.001), MLR (0.23 ± 0.06 vs. 0.28 ± 0.10; p = 0.011), PLR (107.4 ± 37.3 vs. 135.8 ± 58.0; p = 0.013), and SII (445.3 ± 166.3 vs. 675.3 ± 334.0; p < 0.001) were significantly different between responder and non-responder groups. Receiver operator characteristics analysis showed the NLR (AUC 0.778; 95% CI 0.669 to 0.864), PLR (AUC 0.628; 95% CI 0.511 to 0.735), MLR (AUC 0.653; 95% CI 0.536 to 0.757), and SII (AUC 0.709; 95% CI 0.595 to 0.806) could be predictors of response to bevacizumab in patients with DME and NPDR.

Patients with severe NPDR had a significantly higher ApoB/ApoA-I ratio (0.70 (0.57 to 0.87) vs. 0.61 (0.49 to 0.72), p = 0.049) and lower vitamin D (52.45 (43.10 to 70.60) ng/mL vs. 40.05 (25.95 to 55.30) ng/mL, p = 0.025). Alterations in the NLR, PLR, MLR, and SII seem to provide prognostic information regarding the response to bevacizumab in patients with DME, whilst vitamin D deficiency and the ApoB/ApoA-I ratio could contribute to better staging.

Authors’ abstract

The aim of this study was to establish whether multiple blood parameters might predict an early treatment response to intravitreal bevacizumab injections in patients with diabetic macular edema (DME). Seventy-eight patients with non-proliferative diabetic retinopathy (NPDR) and DME were included. The treatment response was evaluated with central macular thickness decrease and best corrected visual acuity increase one month after the last bevacizumab injection. Parameters of interest were the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), vitamin D, and apolipoprotein B to A-I ratio (ApoB/ApoA-I).

The NLR (2.03 ± 0.70 vs. 2.80 ± 1.08; p < 0.001), MLR (0.23 ± 0.06 vs. 0.28 ± 0.10; p = 0.011), PLR (107.4 ± 37.3 vs. 135.8 ± 58.0; p = 0.013), and SII (445.3 ± 166.3 vs. 675.3 ± 334.0; p < 0.001) were significantly different between responder and non-responder groups. Receiver operator characteristics analysis showed the NLR (AUC 0.778; 95% CI 0.669 to 0.864), PLR (AUC 0.628; 95% CI 0.511 to 0.735), MLR (AUC 0.653; 95% CI 0.536 to 0.757), and SII (AUC 0.709; 95% CI 0.595 to 0.806) could be predictors of response to bevacizumab in patients with DME and NPDR.

Patients with severe NPDR had a significantly higher ApoB/ApoA-I ratio (0.70 (0.57 to 0.87) vs. 0.61 (0.49 to 0.72), p = 0.049) and lower vitamin D (52.45 (43.10 to 70.60) ng/mL vs. 40.05 (25.95 to 55.30) ng/mL, p = 0.025). Alterations in the NLR, PLR, MLR, and SII seem to provide prognostic information regarding the response to bevacizumab in patients with DME, whilst vitamin D deficiency and the ApoB/ApoA-I ratio could contribute to better staging.

Publication and source details

Original title: The Predictors of Early Treatment Effectiveness of Intravitreal Bevacizumab Application in Patients with Diabetic Macular Edema

Karla Katić; Josip Katić; Marko Kumrić; Joško Božić; Leida Tandara; Daniela Šupe Domić; Kajo Bućan

Diagnostics · 2024

* Correspondence: gudelj.karla@yahoo.com (K.K.); kbucan@kbsplit.hr (K.B.)© 2024 by the authors.2024https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).PhD program TRIBE (Translational Research in Biomedicine) of the University of Split School of MedicinePhD program TRIBE (Translational Research in Biomedicine) of the University of Split School of Medicine funded the reagents used in the study.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:35:31.918865+00:00

DOI: 10.3390/diagnostics14100992 · PMC11120272